$873.68
0.560.06%
At close: -
$872.29
-1.39-0.16%
After Hours: 7:55 PM EDT
Eli Lilly reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Eli Lilly using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-06 | $5.32 | $5.08 | 4.72 % |
Q3 | 2024-10-30 | $1.18 | $1.45 | -18.6 % |
Q2 | 2024-08-08 | $3.92 | $2.70 | 45.2 % |
Q1 | 2024-04-30 | $2.58 | $2.46 | 4.88 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-06 | $13.53B | $13.43B | 0.77 % |
Q3 | 2024-10-30 | $11.44B | $12.10B | -5.46 % |
Q2 | 2024-08-08 | $11.30B | $9.95B | 13.6 % |
Q1 | 2024-04-30 | $8.77B | $8.92B | -1.70 % |
Eli Lilly (LLY) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 6, 2025 for Q4.
The Actual EPS was $5.32, which beat the estimate of $5.08.
The Actual Revenue was $13.5B, which beat the estimate of $13.4B.
Browse earnings estimates, EPS, and revenue on all stocks.